PHARMACY

Georgia Winn-Dixie pharmacies offer discount Rxs for $3.99

BY Jenna Duncan

DUBLIN and BONAIRE, Ga. Two Georgia Winn-Dixie stores are now offering more than 400 generic prescription drugs for $3.99 for a 30-day supply, local reports said today.

Winn-Dixie has said that 60-day supply of drugs on the discount prescription list are being offered for $7.98 and 90-day supplies are available for $9.99.

Additionally, select women’s health prescriptions will be offered for $8.99 for 30-day scripts and $23.99 for 90-day scripts.

No special enrollment or fees are required to participate in the discount prescription program, Winn-Dixie has said. The program will be available at the Winn-Dixie store at 2101 Veterans Blvd. in Dublin, Ga., and also at 785 Highway 96 in Bonaire, Ga.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA, SciClone meet agreement on distribution of melanoma treatment

BY Alaric DeArment

NEW YORK The Food and Drug Administration has reached an agreement with a drug maker on the design of a phase 3 trial of a skin cancer drug.

SciClone Pharmaceuticals announced Monday that it had reached the agreement with the agency concerning the drug thymalfasin, which it sees as a potential treatment for stage 4 melanoma.

“Patients suffering from stage 4 melanoma have very few treatment options available,” SciClone chief medical officer Israel Rios said in a statement. “Based on the positive data from an earlier phase 2 trial, thymalfasin could provide new treatment modalities for this high unmet medical need.”

The drug, if approved, will be sold under the brand name Zadaxin. The full name of its active ingredient is thymosin alpha 1.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Teva releases generic version of AstraZeneca’s Pulmicort

BY Alaric DeArment

NORTH WALES, Pa. The world’s largest maker of generic drugs has introduced a generic version of AstraZeneca’s Pulmicort Respules.

Teva announced Wednesday that it had launched budesonide inhalation suspension, a treatment for asthma, in 0.25-mg-per-2-milliliters and 0.5-mg-per-2-milliliter strengths.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?